IGM Biosciences
IGMS
$9.35
Share price
-1.36%
Change (1 day)
-19.74%
Change (1 year)
Categories
IGM Biosciences (IGMS) - Cash on Hand
Cash on Hand as of December 2023 : $0.33 B
According to IGM Biosciences's latest financial reports the company has $0.33 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
IGM Biosciences - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.33 B | -20.95% |
| 2022-12-31 | $0.42 B | 86.09% |
| 2021-12-31 | $0.22 B | -37.33% |
| 2020-12-31 | $0.36 B | 63.05% |
| 2019-12-31 | $0.22 B | 11804.29% |
| 2018-12-31 | $1.88 M | 336.81% |
| 2017-12-31 | $0.43 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -38.35% | 🇺🇸 USA |